277 related articles for article (PubMed ID: 14663358)
1. Diagnostic value of microtubule-associated protein-2 in Merkel cell carcinoma.
Liu Y; Mangini J; Saad R; Silverman AR; Abell E; Tung MY; Graner SR; Silverman JF
Appl Immunohistochem Mol Morphol; 2003 Dec; 11(4):326-9. PubMed ID: 14663358
[TBL] [Abstract][Full Text] [Related]
2. CD99 expression in Merkel cell carcinoma: a case series with an unusual paranuclear dot-like staining pattern.
Rajagopalan A; Browning D; Salama S
J Cutan Pathol; 2013 Jan; 40(1):19-24. PubMed ID: 23145531
[TBL] [Abstract][Full Text] [Related]
3. A Rare Case of CK20/CK7 Double Negative Merkel Cell Carcinoma.
Le MD; OʼSteen LH; Cassarino DS
Am J Dermatopathol; 2017 Mar; 39(3):208-211. PubMed ID: 28221211
[TBL] [Abstract][Full Text] [Related]
4. Basal cell carcinoma: CD56 and cytokeratin 5/6 staining patterns in the differential diagnosis with Merkel cell carcinoma.
Panse G; McNiff JM; Ko CJ
J Cutan Pathol; 2017 Jun; 44(6):553-556. PubMed ID: 28403527
[TBL] [Abstract][Full Text] [Related]
5. Merkel cell carcinoma with an unusual immunohistochemical profile.
Pilloni L; Manieli C; Senes G; Ribuffo D; Faa G
Eur J Histochem; 2009 Dec; 53(4):e33. PubMed ID: 22073365
[TBL] [Abstract][Full Text] [Related]
6. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
7. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin.
Nicholson SA; McDermott MB; Swanson PE; Wick MR
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):37-41. PubMed ID: 10937047
[TBL] [Abstract][Full Text] [Related]
8. INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma.
Lilo MT; Chen Y; LeBlanc RE
Am J Surg Pathol; 2018 Nov; 42(11):1541-1548. PubMed ID: 30080705
[TBL] [Abstract][Full Text] [Related]
9. Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma.
Stanoszek LM; Chan MP; Palanisamy N; Carskadon S; Siddiqui J; Patel RM; Harms KL; Lowe L; Fullen DR; Harms PW
Histopathology; 2019 Feb; 74(3):504-513. PubMed ID: 30239030
[TBL] [Abstract][Full Text] [Related]
10. Frequent expression of glypican-3 in Merkel cell carcinoma: an immunohistochemical study of 55 cases.
He H; Fang W; Liu X; Weiss LM; Chu PG
Appl Immunohistochem Mol Morphol; 2009 Jan; 17(1):40-6. PubMed ID: 18813128
[TBL] [Abstract][Full Text] [Related]
11. A case series and immunophenotypic analysis of CK20-/CK7+ primary neuroendocrine carcinoma of the skin.
Calder KB; Coplowitz S; Schlauder S; Morgan MB
J Cutan Pathol; 2007 Dec; 34(12):918-23. PubMed ID: 18001414
[TBL] [Abstract][Full Text] [Related]
12. Differentiating Merkel cell carcinoma of lymph nodes without a detectable primary skin tumor from other metastatic neuroendocrine carcinomas: The ELECTHIP criteria.
Kervarrec T; Zaragoza J; Gaboriaud P; Le Gouge A; Beby-Defaux A; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Michenet P; Maillard H; Touzé A; Samimi M; Guyétant S
J Am Acad Dermatol; 2018 May; 78(5):964-972.e3. PubMed ID: 29180096
[TBL] [Abstract][Full Text] [Related]
13. Differentiation between merkel cell carcinoma and malignant melanoma: An immunohistochemical study.
Kontochristopoulos GJ; Stavropoulos PG; Krasagakis K; Goerdt S; Zouboulis CC
Dermatology; 2000; 201(2):123-6. PubMed ID: 11053914
[TBL] [Abstract][Full Text] [Related]
14. Utility of CD99 Paranuclear Expression in the Differential Diagnosis of Merkel Cell Carcinoma.
Domínguez-Malagón HR; Michal M; Kazakov DV; Caro-Sánchez CH; Lino-Silva LS
Int J Surg Pathol; 2016 Jun; 24(4):293-6. PubMed ID: 26782152
[TBL] [Abstract][Full Text] [Related]
15. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma.
Cho WC; Vanderbeck K; Nagarajan P; Milton DR; Gill P; Wang WL; Curry JL; Torres-Cabala CA; Ivan D; Prieto VG; Aung PP
Arch Pathol Lab Med; 2023 Jul; 147(7):758-766. PubMed ID: 36745184
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma of the eyelid: histological and immunohistochemical features with special respect to differential diagnosis.
Metz KA; Jacob M; Schmidt U; Steuhl KP; Leder LD
Graefes Arch Clin Exp Ophthalmol; 1998 Aug; 236(8):561-6. PubMed ID: 9717649
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin staining in Merkel cell carcinoma: an immunohistochemical study of cytokeratins 5/6, 7, 17, and 20.
Jensen K; Kohler S; Rouse RV
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):310-5. PubMed ID: 11127923
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological spectrum of a series of Merkel cell carcinomas diagnosed at a tertiary cancer referral center in India, with current concepts.
Rekhi B; Kane SV; Jambhekar NA
Ann Diagn Pathol; 2015 Oct; 19(5):341-6. PubMed ID: 26254510
[TBL] [Abstract][Full Text] [Related]
19. Evidence of proliferative activity in human Merkel cells: implications in the histogenesis of Merkel cell carcinoma.
Narisawa Y; Inoue T; Nagase K
Arch Dermatol Res; 2019 Jan; 311(1):37-43. PubMed ID: 30460510
[TBL] [Abstract][Full Text] [Related]
20. TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis.
Sur M; AlArdati H; Ross C; Alowami S
Mod Pathol; 2007 Nov; 20(11):1113-20. PubMed ID: 17885674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
